Schedule 13D ownership disclosure

Benitec Biopharma Inc

Security class unavailable · CUSIP: 08205P209

Event date: 2024-04-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,478,490
Percent of class
17.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-24-000506
Form type
SC 13D
Filer
Benitec Biopharma Inc.
CIK
CIK 1808898
Filed
Apr 29, 2024
Reporting period
Apr 22, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub